世界の抗感染API市場2021-2026:β-ラクタム薬、マクロライド系抗生物質、カルバペネム系抗生物質、キノロン系抗生物質

LP Informationが発行した調査報告書(LPI21MY0707)
◆英語タイトル:Global Anti-infective API Market Growth 2021-2026
◆商品コード:LPI21MY0707
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年5月(※2024年版があります。お問い合わせください)
◆ページ数:137
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:化学&材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LPインフォメーション社の「抗感染APIの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、β-ラクタム薬、マクロライド系抗生物質、カルバペネム系抗生物質、キノロン系抗生物質など、用途別には、全身用抗菌薬、全身用抗ウイルス薬、全身用抗原、細菌、免疫血清・免疫グロブリン、抗酸菌薬、ワクチン、その他などにセグメント区分してまとめました。抗感染APIのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・抗感染APIの世界市場概要(サマリー)
・抗感染APIの企業別販売量・売上
・抗感染APIの企業別市場シェア
・抗感染APIの世界市場規模 2016年-2021年:種類別(β-ラクタム薬、マクロライド系抗生物質、カルバペネム系抗生物質、キノロン系抗生物質)
・抗感染APIの世界市場規模 2016年-2021年:用途別(全身用抗菌薬、全身用抗ウイルス薬、全身用抗原、細菌、免疫血清・免疫グロブリン、抗酸菌薬、ワクチン、その他)
・抗感染APIの南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・抗感染APIのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・抗感染APIのヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・抗感染APIの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・抗感染API市場の成長要因・課題・動向
・抗感染APIの世界市場予測 2021年-2026年
・抗感染APIの南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・抗感染APIのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・抗感染APIのヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・抗感染APIの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・抗感染APIの世界市場予測:種類別(β-ラクタム薬、マクロライド系抗生物質、カルバペネム系抗生物質、キノロン系抗生物質)
・抗感染APIの世界市場予測:用途別(全身用抗菌薬、全身用抗ウイルス薬、全身用抗原、細菌、免疫血清・免疫グロブリン、抗酸菌薬、ワクチン、その他)
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Anti-infective API will have significant change from previous year. By the most conservative estimates of global Anti-infective API market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Anti-infective API market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-infective API market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
β-lactam Drugs
Macrolides
Carbapenems
Quinolones

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Antibacterial Drugs for Systemic Use
Antiviral Drugs for Systemic Use
Antigen for Whole Body
Bacteria
Immune Serum and Immunoglobulin
Anti-mycobacterial Drugs
Vaccine
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
North China Pharmaceutical
CSPC
Harbin Pharmaceutical Group Pharmaceutical General Factory
Henan Huaxing Pharmaceutical Factory
Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
Zhangjiakou Diha Pharmaceutical
Shandong Lukang Medicine
Zhuhai United Laboratories
Lunan Pharmaceutical Group
Sandoz

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-infective API Consumption 2016-2026
2.1.2 Anti-infective API Consumption CAGR by Region
2.2 Anti-infective API Segment by Type
2.2.1 β-lactam Drugs
2.2.2 Macrolides
2.2.3 Carbapenems
2.2.4 Quinolones
2.3 Anti-infective API Sales by Type
2.3.1 Global Anti-infective API Sales Market Share by Type (2016-2021)
2.3.2 Global Anti-infective API Revenue and Market Share by Type (2016-2021)
2.3.3 Global Anti-infective API Sale Price by Type (2016-2021)
2.4 Anti-infective API Segment by Application
2.4.1 Antibacterial Drugs for Systemic Use
2.4.2 Antiviral Drugs for Systemic Use
2.4.3 Antigen for Whole Body
2.4.4 Bacteria
2.4.5 Immune Serum and Immunoglobulin
2.4.6 Anti-mycobacterial Drugs
2.4.7 Vaccine
2.4.8 Other
2.5 Anti-infective API Sales by Application
2.5.1 Global Anti-infective API Sale Market Share by Application (2016-2021)
2.5.2 Global Anti-infective API Revenue and Market Share by Application (2016-2021)
2.5.3 Global Anti-infective API Sale Price by Application (2016-2021)

3 Global Anti-infective API by Company
3.1 Global Anti-infective API Sales Market Share by Company
3.1.1 Global Anti-infective API Sales by Company (2019-2021)
3.1.2 Global Anti-infective API Sales Market Share by Company (2019-2021)
3.2 Global Anti-infective API Revenue Market Share by Company
3.2.1 Global Anti-infective API Revenue by Company (2019-2021)
3.2.2 Global Anti-infective API Revenue Market Share by Company (2019-2021)
3.3 Global Anti-infective API Sale Price by Company
3.4 Global Manufacturers Anti-infective API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-infective API Product Location Distribution
3.4.2 Players Anti-infective API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Anti-infective API by Region
4.1 Global Anti-infective API by Region
4.1.1 Global Anti-infective API Sales by Region
4.1.2 Global Anti-infective API Revenue by Region
4.2 Americas Anti-infective API Sales Growth
4.3 APAC Anti-infective API Sales Growth
4.4 Europe Anti-infective API Sales Growth
4.5 Middle East & Africa Anti-infective API Sales Growth

5 Americas
5.1 Americas Anti-infective API Sales by Country
5.1.1 Americas Anti-infective API Sales by Country (2016-2021)
5.1.2 Americas Anti-infective API Revenue by Country (2016-2021)
5.2 Americas Anti-infective API Sales by Type
5.3 Americas Anti-infective API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Anti-infective API Sales by Region
6.1.1 APAC Anti-infective API Sales by Region (2016-2021)
6.1.2 APAC Anti-infective API Revenue by Region (2016-2021)
6.2 APAC Anti-infective API Sales by Type
6.3 APAC Anti-infective API Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Anti-infective API by Country
7.1.1 Europe Anti-infective API Sales by Country (2016-2021)
7.1.2 Europe Anti-infective API Revenue by Country (2016-2021)
7.2 Europe Anti-infective API Sales by Type
7.3 Europe Anti-infective API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Anti-infective API by Country
8.1.1 Middle East & Africa Anti-infective API Sales by Country (2016-2021)
8.1.2 Middle East & Africa Anti-infective API Revenue by Country (2016-2021)
8.2 Middle East & Africa Anti-infective API Sales by Type
8.3 Middle East & Africa Anti-infective API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Anti-infective API Distributors
10.3 Anti-infective API Customer

11 Global Anti-infective API Market Forecast
11.1 Global Anti-infective API Forecast by Region
11.1.1 Global Anti-infective API Forecast by Regions (2021-2026)
11.2.2 Global Anti-infective API Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Anti-infective API Forecast by Type
11.7 Global Anti-infective API Forecast by Application

12 Key Players Analysis
12.1 North China Pharmaceutical
12.1.1 North China Pharmaceutical Company Information
12.1.2 North China Pharmaceutical Anti-infective API Product Offered
12.1.3 North China Pharmaceutical Anti-infective API Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 North China Pharmaceutical Main Business Overview
12.1.5 North China Pharmaceutical Latest Developments
12.2 CSPC
12.2.1 CSPC Company Information
12.2.2 CSPC Anti-infective API Product Offered
12.2.3 CSPC Anti-infective API Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 CSPC Main Business Overview
12.2.5 CSPC Latest Developments
12.3 Harbin Pharmaceutical Group Pharmaceutical General Factory
12.3.1 Harbin Pharmaceutical Group Pharmaceutical General Factory Company Information
12.3.2 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Product Offered
12.3.3 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Harbin Pharmaceutical Group Pharmaceutical General Factory Main Business Overview
12.3.5 Harbin Pharmaceutical Group Pharmaceutical General Factory Latest Developments
12.4 Henan Huaxing Pharmaceutical Factory
12.4.1 Henan Huaxing Pharmaceutical Factory Company Information
12.4.2 Henan Huaxing Pharmaceutical Factory Anti-infective API Product Offered
12.4.3 Henan Huaxing Pharmaceutical Factory Anti-infective API Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Henan Huaxing Pharmaceutical Factory Main Business Overview
12.4.5 Henan Huaxing Pharmaceutical Factory Latest Developments
12.5 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
12.5.1 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Company Information
12.5.2 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Product Offered
12.5.3 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Main Business Overview
12.5.5 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Latest Developments
12.6 Zhangjiakou Diha Pharmaceutical
12.6.1 Zhangjiakou Diha Pharmaceutical Company Information
12.6.2 Zhangjiakou Diha Pharmaceutical Anti-infective API Product Offered
12.6.3 Zhangjiakou Diha Pharmaceutical Anti-infective API Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Zhangjiakou Diha Pharmaceutical Main Business Overview
12.6.5 Zhangjiakou Diha Pharmaceutical Latest Developments
12.7 Shandong Lukang Medicine
12.7.1 Shandong Lukang Medicine Company Information
12.7.2 Shandong Lukang Medicine Anti-infective API Product Offered
12.7.3 Shandong Lukang Medicine Anti-infective API Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Shandong Lukang Medicine Main Business Overview
12.7.5 Shandong Lukang Medicine Latest Developments
12.8 Zhuhai United Laboratories
12.8.1 Zhuhai United Laboratories Company Information
12.8.2 Zhuhai United Laboratories Anti-infective API Product Offered
12.8.3 Zhuhai United Laboratories Anti-infective API Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Zhuhai United Laboratories Main Business Overview
12.8.5 Zhuhai United Laboratories Latest Developments
12.9 Lunan Pharmaceutical Group
12.9.1 Lunan Pharmaceutical Group Company Information
12.9.2 Lunan Pharmaceutical Group Anti-infective API Product Offered
12.9.3 Lunan Pharmaceutical Group Anti-infective API Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Lunan Pharmaceutical Group Main Business Overview
12.9.5 Lunan Pharmaceutical Group Latest Developments
12.10 Sandoz
12.10.1 Sandoz Company Information
12.10.2 Sandoz Anti-infective API Product Offered
12.10.3 Sandoz Anti-infective API Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Sandoz Main Business Overview
12.10.5 Sandoz Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Anti-infective API Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of β-lactam Drugs
Table 3. Major Players of Macrolides
Table 4. Major Players of Carbapenems
Table 5. Major Players of Quinolones
Table 6. Global Anti-infective API Sales by Type (2016-2021) & (Kiloton)
Table 7. Global Anti-infective API Sales Market Share by Type (2016-2021)
Table 8. Global Anti-infective API Revenue by Type (2016-2021) & ($ million)
Table 9. Global Anti-infective API Revenue Market Share by Type (2016-2021)
Table 10. Global Anti-infective API Sale Price by Type (2016-2021)
Table 11. Global Anti-infective API Sales by Application (2016-2021) & (Kiloton)
Table 12. Global Anti-infective API Sales Market Share by Application (2016-2021)
Table 13. Global Anti-infective API Value by Application (2016-2021)
Table 14. Global Anti-infective API Revenue Market Share by Application (2016-2021)
Table 15. Global Anti-infective API Sale Price by Application (2016-2021)
Table 16. Global Anti-infective API Sales by Company (2019-2021) & (Kiloton)
Table 17. Global Anti-infective API Sales Market Share by Company (2019-2021)
Table 18. Global Anti-infective API Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Anti-infective API Revenue Market Share by Company (2019-2021)
Table 20. Global Anti-infective API Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Anti-infective API Producing Area Distribution and Sales Area
Table 22. Players Anti-infective API Products Offered
Table 23. Anti-infective API Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Anti-infective API Sales by Region (2016-2021) (Kiloton)
Table 27. Global Anti-infective API Sales Market Share by Region (2016-2021)
Table 28. Global Anti-infective API Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Anti-infective API Revenue Market Share by Region (2016-2021)
Table 30. Americas Anti-infective API Sales by Country (2016-2021) & (Kiloton)
Table 31. Americas Anti-infective API Sales Market Share by Country (2016-2021)
Table 32. Americas Anti-infective API Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Anti-infective API Revenue Market Share by Country (2016-2021)
Table 34. Americas Anti-infective API Sales by Type (2016-2021) & (Kiloton)
Table 35. Americas Anti-infective API Sales Market Share by Type (2016-2021)
Table 36. Americas Anti-infective API Sales by Application (2016-2021) & (Kiloton)
Table 37. Americas Anti-infective API Sales Market Share by Application (2016-2021)
Table 38. APAC Anti-infective API Sales by Region (2016-2021) & (Kiloton)
Table 39. APAC Anti-infective API Sales Market Share by Region (2016-2021)
Table 40. APAC Anti-infective API Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Anti-infective API Revenue Market Share by Region (2016-2021)
Table 42. APAC Anti-infective API Sales by Type (2016-2021) & (Kiloton)
Table 43. APAC Anti-infective API Sales Market Share by Type (2016-2021)
Table 44. APAC Anti-infective API Sales by Application (2016-2021) & (Kiloton)
Table 45. APAC Anti-infective API Sales Market Share by Application (2016-2021)
Table 46. Europe Anti-infective API Sales by Country (2016-2021) & (Kiloton)
Table 47. Europe Anti-infective API Sales Market Share by Country (2016-2021)
Table 48. Europe Anti-infective API Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Anti-infective API Revenue Market Share by Country (2016-2021)
Table 50. Europe Anti-infective API Sales by Type (2016-2021) & (Kiloton)
Table 51. Europe Anti-infective API Sales Market Share by Type (2016-2021)
Table 52. Europe Anti-infective API Sales by Application (2016-2021) & (Kiloton)
Table 53. Europe Anti-infective API Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Anti-infective API Sales by Country (2016-2021) & (Kiloton)
Table 55. Middle East & Africa Anti-infective API Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Anti-infective API Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Anti-infective API Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Anti-infective API Sales by Type (2016-2021) & (Kiloton)
Table 59. Middle East & Africa Anti-infective API Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Anti-infective API Sales by Application (2016-2021) & (Kiloton)
Table 61. Middle East & Africa Anti-infective API Sales Market Share by Application (2016-2021)
Table 62. Key and Potential Regions of Anti-infective API
Table 63. Key Application and Potential Industries of Anti-infective API
Table 64. Key Challenges of Anti-infective API
Table 65. Key Trends of Anti-infective API
Table 66. Anti-infective API Distributors List
Table 67. Anti-infective API Customer List
Table 68. Global Anti-infective API Sales Forecast by Region (2021-2026) & (Kiloton)
Table 69. Global Anti-infective API Consumption Market Forecast by Region
Table 70. Global Anti-infective API Revenue Forecast by Region (2021-2026) & ($ millions)
Table 71. Global Anti-infective API Revenue Market Share Forecast by Region (2021-2026)
Table 72. Americas Anti-infective API Sales Forecast by Country (2021-2026) & (Kiloton)
Table 73. Americas Anti-infective API Revenue Forecast by Country (2021-2026) & ($ millions)
Table 74. APAC Anti-infective API Sales Forecast by Region (2021-2026) & (Kiloton)
Table 75. APAC Anti-infective API Revenue Forecast by Region (2021-2026) & ($ millions)
Table 76. Europe Anti-infective API Sales Forecast by Country (2021-2026) & (Kiloton)
Table 77. Europe Anti-infective API Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Middle East & Africa Anti-infective API Sales Forecast by Country (2021-2026) & (Kiloton)
Table 79. Middle East & Africa Anti-infective API Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Global Anti-infective API Sales Forecast by Type (2021-2026) & (Kiloton)
Table 81. Global Anti-infective API Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Anti-infective API Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 83. Global Anti-infective API Revenue Market Share Forecast by Type (2021-2026)
Table 84. Global Anti-infective API Sales Forecast by Application (2021-2026) & (Kiloton)
Table 85. Global Anti-infective API Sales Market Share Forecast by Application (2021-2026)
Table 86. Global Anti-infective API Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 87. Global Anti-infective API Revenue Market Share Forecast by Application (2021-2026)
Table 88. North China Pharmaceutical Basic Information, Anti-infective API Manufacturing Base, Sales Area and Its Competitors
Table 89. North China Pharmaceutical Anti-infective API Product Offered
Table 90. North China Pharmaceutical Anti-infective API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 91. North China Pharmaceutical Main Business
Table 92. North China Pharmaceutical Latest Developments
Table 93. CSPC Basic Information, Anti-infective API Manufacturing Base, Sales Area and Its Competitors
Table 94. CSPC Anti-infective API Product Offered
Table 95. CSPC Anti-infective API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 96. CSPC Main Business
Table 97. CSPC Latest Developments
Table 98. Harbin Pharmaceutical Group Pharmaceutical General Factory Basic Information, Anti-infective API Manufacturing Base, Sales Area and Its Competitors
Table 99. Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Product Offered
Table 100. Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 101. Harbin Pharmaceutical Group Pharmaceutical General Factory Main Business
Table 102. Harbin Pharmaceutical Group Pharmaceutical General Factory Latest Developments
Table 103. Henan Huaxing Pharmaceutical Factory Basic Information, Anti-infective API Manufacturing Base, Sales Area and Its Competitors
Table 104. Henan Huaxing Pharmaceutical Factory Anti-infective API Product Offered
Table 105. Henan Huaxing Pharmaceutical Factory Anti-infective API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 106. Henan Huaxing Pharmaceutical Factory Main Business
Table 107. Henan Huaxing Pharmaceutical Factory Latest Developments
Table 108. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Basic Information, Anti-infective API Manufacturing Base, Sales Area and Its Competitors
Table 109. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Product Offered
Table 110. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 111. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Main Business
Table 112. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Latest Developments
Table 113. Zhangjiakou Diha Pharmaceutical Basic Information, Anti-infective API Manufacturing Base, Sales Area and Its Competitors
Table 114. Zhangjiakou Diha Pharmaceutical Anti-infective API Product Offered
Table 115. Zhangjiakou Diha Pharmaceutical Anti-infective API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 116. Zhangjiakou Diha Pharmaceutical Main Business
Table 117. Zhangjiakou Diha Pharmaceutical Latest Developments
Table 118. Shandong Lukang Medicine Basic Information, Anti-infective API Manufacturing Base, Sales Area and Its Competitors
Table 119. Shandong Lukang Medicine Anti-infective API Product Offered
Table 120. Shandong Lukang Medicine Anti-infective API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 121. Shandong Lukang Medicine Main Business
Table 122. Shandong Lukang Medicine Latest Developments
Table 123. Zhuhai United Laboratories Basic Information, Anti-infective API Manufacturing Base, Sales Area and Its Competitors
Table 124. Zhuhai United Laboratories Anti-infective API Product Offered
Table 125. Zhuhai United Laboratories Anti-infective API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 126. Zhuhai United Laboratories Main Business
Table 127. Zhuhai United Laboratories Latest Developments
Table 128. Lunan Pharmaceutical Group Basic Information, Anti-infective API Manufacturing Base, Sales Area and Its Competitors
Table 129. Lunan Pharmaceutical Group Anti-infective API Product Offered
Table 130. Lunan Pharmaceutical Group Anti-infective API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 131. Lunan Pharmaceutical Group Main Business
Table 132. Lunan Pharmaceutical Group Latest Developments
Table 133. Sandoz Basic Information, Anti-infective API Manufacturing Base, Sales Area and Its Competitors
Table 134. Sandoz Anti-infective API Product Offered
Table 135. Sandoz Anti-infective API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 136. Sandoz Main Business
Table 137. Sandoz Latest Developments
List of Figures
Figure 1. Picture of Anti-infective API
Figure 2. Anti-infective API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-infective API Sales Growth Rate 2016-2026 (Kiloton)
Figure 7. Global Anti-infective API Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Anti-infective API Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of β-lactam Drugs
Figure 10. Product Picture of Macrolides
Figure 11. Product Picture of Carbapenems
Figure 12. Product Picture of Quinolones
Figure 13. Global Anti-infective API Sales Market Share by Type in 2020
Figure 14. Global Anti-infective API Revenue Market Share by Type (2016-2021)
Figure 15. Anti-infective API Consumed in Antibacterial Drugs for Systemic Use
Figure 16. Global Anti-infective API Market: Antibacterial Drugs for Systemic Use (2016-2021) & (Kiloton)
Figure 17. Anti-infective API Consumed in Antiviral Drugs for Systemic Use
Figure 18. Global Anti-infective API Market: Antiviral Drugs for Systemic Use (2016-2021) & (Kiloton)
Figure 19. Anti-infective API Consumed in Antigen for Whole Body
Figure 20. Global Anti-infective API Market: Antigen for Whole Body (2016-2021) & (Kiloton)
Figure 21. Anti-infective API Consumed in Bacteria
Figure 22. Global Anti-infective API Market: Bacteria (2016-2021) & (Kiloton)
Figure 23. Anti-infective API Consumed in Immune Serum and Immunoglobulin
Figure 24. Global Anti-infective API Market: Immune Serum and Immunoglobulin (2016-2021) & (Kiloton)
Figure 25. Anti-infective API Consumed in Anti-mycobacterial Drugs
Figure 26. Global Anti-infective API Market: Anti-mycobacterial Drugs (2016-2021) & (Kiloton)
Figure 27. Anti-infective API Consumed in Vaccine
Figure 28. Global Anti-infective API Market: Vaccine (2016-2021) & (Kiloton)
Figure 29. Anti-infective API Consumed in Other
Figure 30. Global Anti-infective API Market: Other (2016-2021) & (Kiloton)
Figure 31. Global Anti-infective API Sales Market Share by Application (2016-2021)
Figure 32. Global Anti-infective API Revenue Market Share by Application in 2020
Figure 33. Anti-infective API Revenue Market by Company in 2020 ($ Million)
Figure 34. Global Anti-infective API Revenue Market Share by Company in 2020
Figure 35. Global Anti-infective API Sales Market Share by Regions (2016-2021)
Figure 36. Global Anti-infective API Revenue Market Share by Region in 2020
Figure 37. Americas Anti-infective API Sales 2016-2021 (Kiloton)
Figure 38. Americas Anti-infective API Revenue 2016-2021 ($ Millions)
Figure 39. APAC Anti-infective API Sales 2016-2021 (Kiloton)
Figure 40. APAC Anti-infective API Revenue 2016-2021 ($ Millions)
Figure 41. Europe Anti-infective API Sales 2016-2021 (Kiloton)
Figure 42. Europe Anti-infective API Revenue 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Anti-infective API Sales 2016-2021 (Kiloton)
Figure 44. Middle East & Africa Anti-infective API Revenue 2016-2021 ($ Millions)
Figure 45. Americas Anti-infective API Sales Market Share by Country in 2020
Figure 46. Americas Anti-infective API Revenue Market Share by Country in 2020
Figure 47. Americas Anti-infective API Sales Market Share by Type in 2020
Figure 48. Americas Anti-infective API Sales Market Share by Application in 2020
Figure 49. United States Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 50. Canada Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 51. Mexico Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 52. Brazil Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 53. APAC Anti-infective API Sales Market Share by Region in 2020
Figure 54. APAC Anti-infective API Revenue Market Share by Regions in 2020
Figure 55. APAC Anti-infective API Sales Market Share by Type in 2020
Figure 56. APAC Anti-infective API Sales Market Share by Application in 2020
Figure 57. China Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 58. Japan Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 59. Korea Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 60. Southeast Asia Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 61. India Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 62. Australia Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 63. Europe Anti-infective API Sales Market Share by Country in 2020
Figure 64. Europe Anti-infective API Revenue Market Share by Country in 2020
Figure 65. Europe Anti-infective API Sales Market Share by Type in 2020
Figure 66. Europe Anti-infective API Sales Market Share by Application in 2020
Figure 67. Germany Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 68. France Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 69. UK Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 70. Italy Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 71. Russia Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 72. Middle East & Africa Anti-infective API Sales Market Share by Country in 2020
Figure 73. Middle East & Africa Anti-infective API Revenue Market Share by Country in 2020
Figure 74. Middle East & Africa Anti-infective API Sales Market Share by Type in 2020
Figure 75. Middle East & Africa Anti-infective API Sales Market Share by Application in 2020
Figure 76. Egypt Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 77. South Africa Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 78. Israel Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 79. Turkey Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 80. GCC Country Anti-infective API Revenue Growth 2016-2021 ($ Millions)
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles


【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の抗感染API市場2021-2026:β-ラクタム薬、マクロライド系抗生物質、カルバペネム系抗生物質、キノロン系抗生物質(Global Anti-infective API Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。